A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention
Public ClinicalTrials.gov record NCT01327183. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF 2 DOSES OF RO4905417 (R1512) ADMINISTERED TO PATIENTS WITH NON ST-ELEVATION MYOCARDIAL INFARCTION (NON-STEMI) UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This randomized, double-blind, placebo-controlled study will evaluate the efficacy and safety of RO4905417 in patients with non ST-elevation myocardial infarction (Non-STEMI) undergoing percutaneous coronary intervention (PCI). Patients will be randomized to receive an intravenous infusion of either 5 mg/kg RO4905417 or 20 mg/kg RO4905417 or placebo before PCI. Follow-up will be for 4 months.
Study identification
- NCT ID
- NCT01327183
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 532 participants
Conditions and interventions
Conditions
Interventions
- Percutaneous Coronary Intervention (PCI) Procedure
- RO4905417 Drug
- placebo Drug
Procedure · Drug
Eligibility (public fields only)
- Age range
- 19 Years to 74 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2011 (Type not available)
- Primary completion
- Oct 2012 (Actual)
- Completion
- Oct 2012 (Actual)
- Last update posted
- Nov 2, 2016
2011 – 2012
United States locations
- U.S. sites
- 35
- U.S. states
- 24
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | 35801 | — |
| Not listed | Tucson | Arizona | 85710 | — |
| Not listed | Los Angeles | California | 90022 | — |
| Not listed | Salinas | California | 93901 | — |
| Not listed | Littleton | Colorado | 80120 | — |
| Not listed | Farmington | Connecticut | 06030 | — |
| Not listed | Boynton Beach | Florida | 33472 | — |
| Not listed | Kissimmee | Florida | 34741 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | Sarasota | Florida | 34239 | — |
| Not listed | St. Petersburg | Florida | 33701 | — |
| Not listed | Tampa | Florida | 33613 | — |
| Not listed | Vero Beach | Florida | 32960 | — |
| Not listed | Columbus | Georgia | 31904 | — |
| Not listed | Aurora | Illinois | 60504 | — |
| Not listed | Fort Wayne | Indiana | 46804 | — |
| Not listed | Iowa City | Iowa | 52242 | — |
| Not listed | Wichita | Kansas | 67214 | — |
| Not listed | Louisville | Kentucky | 40205 | — |
| Not listed | Shreveport | Louisiana | 71103 | — |
| Not listed | Baltimore | Massachusetts | 21287 | — |
| Not listed | Hyannis | Massachusetts | 02601 | — |
| Not listed | Bay City | Michigan | 48708 | — |
| Not listed | Petoskey | Michigan | 49770 | — |
| Not listed | Saint Paul | Minnesota | 55102 | — |
| Not listed | Ridgewood | New Jersey | 07450 | — |
| Not listed | Johnson City | New York | 13790 | — |
| Not listed | Raleigh | North Carolina | 27610 | — |
| Not listed | Bismarck | North Dakota | 58501 | — |
| Not listed | Springfield | Ohio | 45505 | — |
| Not listed | Toledo | Ohio | 43606 | — |
| Not listed | Oklahoma City | Oklahoma | 73109 | — |
| Not listed | Oklahoma City | Oklahoma | 73120 | — |
| Not listed | Chambersburg | Pennsylvania | 17201 | — |
| Not listed | Houston | Texas | 77024 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01327183, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 2, 2016 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01327183 live on ClinicalTrials.gov.